9d
Pharmaceutical Technology on MSNMerck KGaA reports YE24 earnings growth amid SpringWorks acquisition talksWhile the company is in discussions to acquire SpringWorks, it did not elaborate on these talks in its earnings call.
Hosted on MSN1mon
Merck KGaA (MKGAF) Faces 11% Stock Decline Despite AI-Driven Growth Outlook and Analyst Price Target of €200In this article, we are going to take a look at where Merck KGaA (OTC:MKGAF ... as tensions in the tech sector subsided. European stock pickers are exploring established sectors such as utilities ...
On February 10, 2025, the Group confirmed advanced discussions about a potential acquisition of SpringWorks Therapeutics ( SWTX ), Inc., USA. At the time of the preparation of the Consolidated ...
Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor ...
The board of Merck KGaA (ETR:MRK) has announced that it will pay a dividend of €2.20 per share on the 30th of April. This means the annual payment will be 1.6% of the current stock price ...
Merck KGaA expects earnings and sales growth this year after reporting a rise in annual earnings on temporarily reduced ...
In a report released today, Matthew Weston from UBS maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price target of ...
Idrees Abbas / SOPA Images / LightRocket / Getty Images Shares of SpringWorks Therapeutics soared on Monday following a report that German medical firm Merck KGaA could acquire the company.
Merck KGaA sees forex-adjusted earnings growth of up to 8% this year Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results